NovartisNOVN 
$96.51-1.14%24h
-1.14%24h
Global rank59
Market cap$198.38B
Change 7d-1.17%
YTD Performance0.60%
SP500 benchmarkUnderperform
P/E0
P/S4.25
Revenue$46.66B
Earnings$14.85B
Dividend yield3.7%
Main Sector
Healthcare
Market capitalization of Novartis (NOVN)
As of December 2024, Novartis has a market cap of $198.38B. This makes Novartis the world's 59th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Novartis from 1995 to 2024
-
Value:-
Market cap history of Novartis from 1995 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $200.47B | 3.64% |
| 2023 | $193.43B | 1.53% |
| 2022 | $190.51B | 4.12% |
| 2021 | $182.97B | -4.03% |
| 2020 | $190.65B | -8.98% |
| 2019 | $209.45B | 23.70% |
| 2018 | $169.32B | 1.99% |
| 2017 | $166.02B | 11.20% |
| 2016 | $149.29B | -14.63% |
| 2015 | $174.88B | -6.01% |
| 2014 | $186.06B | 29.71% |
| 2013 | $143.45B | 23.93% |
| 2012 | $115.75B | 6.98% |
| 2011 | $108.19B | -2.27% |
| 2010 | $110.71B | -3.43% |
| 2009 | $114.64B | 7.97% |
| 2008 | $106.18B | -15.14% |
| 2007 | $125.12B | -11.60% |
| 2006 | $141.54B | 1.74% |
| 2005 | $139.12B | 20.51% |
| 2004 | $115.44B | 2.05% |
| 2003 | $113.13B | 11.30% |
| 2002 | $101.64B | -15.92% |
| 2001 | $120.89B | -16.23% |
| 2000 | $144.31B | 8.32% |
| 1999 | $133.22B | -13.41% |
| 1998 | $153.84B | 13.92% |
| 1997 | $135.04B | 61.80% |
| 1996 | $83.46B | 52.54% |
| 1995 | $54.72B | - |
NOVN Market Cap Today is $198.38B -1.14% - 20 Dec 2024
View largest stocks by market cap 
